Literature DB >> 1943654

NMR angiography of coronary vessels with 2-D planar image scanning.

Z H Cho1, C W Mun, R M Friedenberg.   

Abstract

On the basis of the principles of the time-of-flight method and the 3-D angiogram obtained by the 2-D planar image scanning technique using 90 degrees RF pulses with short repetition time, we have obtained a coronary angiogram around the heart including the coronary arteries and veins. The cine NMR imaging technique is also incorporated in synchronizing ECG R waves to reduce the motion artifact and at the same time to induce the saturation effect on the static samples. Images of the large bulk blood flow corresponding to the heart chamber and descending aorta are further removed by postprocessing. The final 3-D angiogram is then formed by stacking the 2-D images and contrast is further enhanced by the maximum ray tracing algorithm.

Entities:  

Mesh:

Year:  1991        PMID: 1943654     DOI: 10.1002/mrm.1910200114

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  4 in total

1.  The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.

Authors:  C Klein; E Nagel; B Schnackenburg; A Bornstedt; S Schalla; V Hoffmann; A Lehning; E Fleck
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

2.  Magnetic resonance coronary artery imaging.

Authors:  C B Paschal; E M Haacke; L P Adler; D A Finelli
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jan-Feb       Impact factor: 2.740

Review 3.  Nonangiographic assessment of coronary artery bypass graft patency.

Authors:  W Stanford; J R Galvin; B H Thompson; M Grover-McKay; D J Skorton
Journal:  Int J Card Imaging       Date:  1993-06

4.  Magnetic resonance imaging planes for the 3-dimensional characterisation of human coronary arteries.

Authors:  A R Gates; C L Huang; J J Crowley; A Gresham; L M Shapiro; T A Carpenter; L D Hall
Journal:  J Anat       Date:  1994-10       Impact factor: 2.610

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.